{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:14:06Z","timestamp":1792019646695,"version":"4.4.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32470681"],"award-info":[{"award-number":["32470681"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170663"],"award-info":[{"award-number":["32170663"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470220"],"award-info":[{"award-number":["82470220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272128"],"award-info":[{"award-number":["82272128"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020732","name":"Innovative Research Team of High-level Local University in Shanghai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.apsb.2025.07.018","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:41:13Z","timestamp":1752712873000},"page":"4411-4426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A computational medicine framework integrating multi-omics, systems biology, and artificial neural networks for Alzheimer's disease therapeutic discovery"],"prefix":"10.1016","volume":"15","author":[{"given":"Yisheng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhu","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanlu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3961-8572","authenticated-orcid":false,"given":"Hai","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.07.018_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"Global, regional, and national burden of Alzheimer's disease and other dementias, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Nichols","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.apsb.2025.07.018_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.apsb.2025.07.018_bib3","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer's disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.apsb.2025.07.018_bib4","doi-asserted-by":"crossref","first-page":"33792","DOI":"10.1021\/acsnano.4c11966","article-title":"Recent progress in nanomedicine for the diagnosis and treatment of Alzheimer's diseases","volume":"18","author":"Yang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.07.018_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113641","article-title":"Lipid nanoparticle (LNP) mediated mRNA delivery in neurodegenerative diseases","volume":"381","author":"Moosavi","year":"2025","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.07.018_bib6","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1038\/s41467-023-43929-1","article-title":"High-throughput target trial emulation for Alzheimer's disease drug repurposing with real-world data","volume":"14","author":"Zang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.07.018_bib7","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/s41467-025-56690-4","article-title":"Drug repurposing for Alzheimer's disease and other neurodegenerative disorders","volume":"16","author":"Cummings","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.07.018_bib8","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1016\/j.cell.2023.09.023","article-title":"Accelerating Alzheimer's therapeutic development: the past and future of clinical trials","volume":"186","author":"Boxer","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2025.07.018_bib9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s43587-024-00630-2","article-title":"The path to next-generation disease-modifying immunomodulatory combination therapies in Alzheimer's disease","volume":"4","author":"Sarazin","year":"2024","journal-title":"Nat Aging"},{"key":"10.1016\/j.apsb.2025.07.018_bib10","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.apsb.2024.12.042","article-title":"A novel anti-ischemic stroke candidate drug AAPB with dual effects of neuroprotection and cerebral blood flow improvement","volume":"15","author":"Wu","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.07.018_bib11","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.apsb.2025.01.015","article-title":"Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer's disease","volume":"15","author":"Wei","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.07.018_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41593-024-01834-w","article-title":"Mapping the cellular etiology of schizophrenia and complex brain phenotypes","volume":"28","author":"Duncan","year":"2025","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.apsb.2025.07.018_bib13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/bib\/bbv048","article-title":"Bioinformatics methods in drug repurposing for Alzheimer's disease","volume":"17","author":"Siavelis","year":"2016","journal-title":"Briefings Bioinf"},{"key":"10.1016\/j.apsb.2025.07.018_bib14","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s43587-021-00122-7","article-title":"Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer's disease","volume":"1","author":"Taubes","year":"2021","journal-title":"Nat Aging"},{"key":"10.1016\/j.apsb.2025.07.018_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13195-020-00760-w","article-title":"AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery","volume":"13","author":"Zhou","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.apsb.2025.07.018_bib16","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/cac2.12215","article-title":"Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine","volume":"41","author":"Chen","year":"2021","journal-title":"Cancer Commun"},{"key":"10.1016\/j.apsb.2025.07.018_bib17","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1002\/alz.13428","article-title":"Artificial intelligence for dementia drug discovery and trials optimization","volume":"19","author":"Doherty","year":"2023","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.apsb.2025.07.018_bib18","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s10462-021-10058-4","article-title":"Machine learning in drug discovery: a review","volume":"55","author":"Dara","year":"2022","journal-title":"Artif Intell Rev"},{"key":"10.1016\/j.apsb.2025.07.018_bib19","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1093\/bioinformatics\/btz418","article-title":"deepDR: a network-based deep learning approach to in silico drug repositioning","volume":"35","author":"Zeng","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2025.07.018_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111717","article-title":"Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer's disease","volume":"41","author":"Xu","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2025.07.018_bib21","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.csbj.2023.02.004","article-title":"AI-DrugNet: a network-based deep learning model for drug repurposing and combination therapy in neurological disorders","volume":"21","author":"Pan","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.apsb.2025.07.018_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105678","article-title":"Synthesize heterogeneous biological knowledge via representation learning for Alzheimer's disease drug repurposing","volume":"26","author":"Hsieh","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.apsb.2025.07.018_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102497","article-title":"AI-driven innovations in Alzheimer's disease: integrating early diagnosis, personalized treatment, and prognostic modelling","volume":"101","author":"Kale","year":"2024","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.apsb.2025.07.018_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41746-024-01038-3","article-title":"Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer's disease with real-world clinical validation","volume":"7","author":"Yan","year":"2024","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.apsb.2025.07.018_bib25","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1038\/s41380-021-01251-6","article-title":"Identification of novel drug targets for Alzheimer's disease by integrating genetics and proteomes from brain and blood","volume":"26","author":"Ou","year":"2021","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.apsb.2025.07.018_bib26","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","article-title":"A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease","volume":"53","author":"Wightman","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2025.07.018_bib27","article-title":"Identification of risk genes for Alzheimer's disease by gene embedding","volume":"2","author":"Lagisetty","year":"2022","journal-title":"Cell Genom"},{"key":"10.1016\/j.apsb.2025.07.018_bib28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer's disease and related dementias","volume":"54","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2025.07.018_bib29","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41588-020-00776-w","article-title":"Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer's disease risk genes","volume":"53","author":"Schwartzentruber","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2025.07.018_bib30","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1109\/TCYB.2023.3344641","article-title":"Prior-guided adversarial learning with hypergraph for predicting abnormal connections in Alzheimer's disease","volume":"54","author":"Zuo","year":"2024","journal-title":"IEEE Trans Cybern"},{"key":"10.1016\/j.apsb.2025.07.018_bib31","doi-asserted-by":"crossref","first-page":"10389","DOI":"10.1109\/TPAMI.2024.3442811","article-title":"A new brain network construction paradigm for brain disorder via diffusion-based graph contrastive learning","volume":"46","author":"Zong","year":"2024","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"10.1016\/j.apsb.2025.07.018_bib32","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","article-title":"Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk","volume":"51","author":"Jansen","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2025.07.018_bib33","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1038\/s41467-021-22491-8","article-title":"Common variants in Alzheimer's disease and risk stratification by polygenic risk scores","volume":"12","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.07.018_bib34","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease","volume":"45","author":"Lambert Jcibrahim-Verbaas CAHarold DNaj ACSims RBellenguez","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2025.07.018_bib35","doi-asserted-by":"crossref","first-page":"D998","DOI":"10.1093\/nar\/gkae1070","article-title":"The NHGRI-EBI GWAS Catalog: standards for reusability, sustainability and diversity","volume":"53","author":"Cerezo","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2025.07.018_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1010932","article-title":"eQTL catalogue 2023: new datasets, X chromosome QTLs, and improved detection and visualisation of transcript-level QTLs","volume":"19","author":"Kerimov","year":"2023","journal-title":"PLoS Genet"},{"key":"10.1016\/j.apsb.2025.07.018_bib37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.07.018_bib38","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/s41588-019-0494-8","article-title":"A compendium of promoter-centered long-range chromatin interactions in the human genome","volume":"51","author":"Jung","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2025.07.018_bib39","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/s41588-019-0472-1","article-title":"Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes","volume":"51","author":"Song","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2025.07.018_bib40","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2025.07.018_bib41","doi-asserted-by":"crossref","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","article-title":"The ChEMBL database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods","volume":"52","author":"Zdrazil","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2025.07.018_bib42","doi-asserted-by":"crossref","first-page":"D1467","DOI":"10.1093\/nar\/gkae1128","article-title":"Open targets platform: facilitating therapeutic hypotheses building in drug discovery","volume":"53","author":"Buniello","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2025.07.018_bib43","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bbrc.2013.11.103","article-title":"supraHex: an R\/Bioconductor package for tabular omics data analysis using a supra-hexagonal map","volume":"443","author":"Fang","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2025.07.018_bib44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.gpb.2018.10.006","article-title":"I3: a self-organising learning workflow for intuitive integrative interpretation of complex genetic data","volume":"17","author":"Tan","year":"2019","journal-title":"Genom Proteom Bioinform"},{"key":"10.1016\/j.apsb.2025.07.018_bib45","article-title":"A cross-disease, pleiotropy-driven approach for therapeutic target prioritization and evaluation","volume":"4","author":"Bao","year":"2024","journal-title":"Cell Rep Methods"},{"key":"10.1016\/j.apsb.2025.07.018_bib46","first-page":"64","article-title":"The \u2018dnet\u2019 approach promotes emerging research on cancer patient survival","volume":"6","author":"Fang","year":"2014","journal-title":"Genome Med"},{"key":"10.1016\/j.apsb.2025.07.018_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13073-016-0384-y","article-title":"XGR software for enhanced interpretation of genomic summary data, illustrated by application to immunological traits","volume":"8","author":"Fang","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.apsb.2025.07.018_bib48","doi-asserted-by":"crossref","first-page":"D1358","DOI":"10.1093\/nar\/gkab994","article-title":"Priority index: database of genetic targets in immune-mediated disease","volume":"50","author":"Fang","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2025.07.018_bib49","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41588-019-0456-1","article-title":"A genetics-led approach defines the drug target landscape of 30 immune-related traits","volume":"51","author":"Fang","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2025.07.018_bib50","doi-asserted-by":"crossref","first-page":"W583","DOI":"10.1093\/nar\/gkac379","article-title":"PiER: web-based facilities tailored for genetic target prioritisation harnessing human disease genetics, functional genomics and protein interactions","volume":"50","author":"Fang","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2025.07.018_bib51","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.cell.2017.05.038","article-title":"An expanded view of complex traits: from polygenic to omnigenic","volume":"169","author":"Boyle","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2025.07.018_bib52","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S2665-9913(19)30134-1","article-title":"From genome-wide association studies to rational drug target prioritisation in inflammatory arthritis","volume":"2","author":"Fang","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.apsb.2025.07.018_bib53","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJMoa2310168","article-title":"Biomarker changes during 20 years preceding Alzheimer's disease","volume":"390","author":"Jia","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2025.07.018_bib54","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer's disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.07.018_bib55","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJMoa2304430","article-title":"Two phase 3 trials of gantenerumab in early Alzheimer's disease","volume":"389","author":"Bateman","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2025.07.018_bib56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of solanezumab for mild dementia due to Alzheimer's disease","volume":"378","author":"Honig","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2025.07.018_bib57","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","article-title":"Trial of solanezumab in preclinical Alzheimer's disease","volume":"389","author":"Sperling","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2025.07.018_bib58","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2025.07.018_bib59","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/jamaneurol.2022.2909","article-title":"Evaluating the safety and efficacy of crenezumab vs placebo in adults with early Alzheimer disease: two phase 3 randomized placebo-controlled trials","volume":"79","author":"Ostrowitzki","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.apsb.2025.07.018_bib60","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s40265-024-02067-8","article-title":"Effects of oral ALZ-801\/valiltramiprosate on plasma biomarkers, brain hippocampal volume, and cognition: results of 2-year single-arm, open-label, phase 2 trial in APOE4 carriers with early Alzheimer's disease","volume":"84","author":"Hey","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.apsb.2025.07.018_bib61","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s40265-024-02068-7","article-title":"Analysis of cerebrospinal fluid, plasma \u03b2-amyloid biomarkers, and cognition from a 2-year phase 2 trial evaluating oral ALZ-801\/valiltramiprosate in APOE4 carriers with early Alzheimer's disease using quantitative systems pharmacology model","volume":"84","author":"Hey","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.apsb.2025.07.018_bib62","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.7150\/thno.98172","article-title":"A novel ferroptosis inhibitor, thonningianin A, improves Alzheimer's disease by activating GPX4","volume":"14","author":"Yong","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.07.018_bib63","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/s41467-022-29498-9","article-title":"ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation","volume":"13","author":"Li","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.07.018_bib64","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1212\/WNL.0000000000206833","article-title":"Estrogen receptor genes, cognitive decline, and Alzheimer disease","volume":"100","author":"Oveisgharan","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.apsb.2025.07.018_bib65","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jama.283.8.1007","article-title":"Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study","volume":"283","author":"Mulnard","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.apsb.2025.07.018_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pharmthera.2018.12.008","article-title":"KIT as a therapeutic target for non-oncological diseases","volume":"197","author":"Martinez-Anton","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2025.07.018_bib67","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13195-023-01169-x","article-title":"Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial","volume":"15","author":"Dubois","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.apsb.2025.07.018_bib68","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkae909","article-title":"KEGG: biological systems database as a model of the real world","volume":"53","author":"Kanehisa","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2025.07.018_bib69","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1038\/s41467-023-41122-y","article-title":"CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer's disease","volume":"14","author":"Del Campo","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.07.018_bib70","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.25775","article-title":"Nilotinib effects on safety, tolerability, and biomarkers in Alzheimer's disease","volume":"88","author":"Turner","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.apsb.2025.07.018_bib71","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa2214131","article-title":"Capivasertib in hormone receptor-positive advanced breast cancer","volume":"388","author":"Turner","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2025.07.018_bib72","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13045-022-01375-4","article-title":"Drugging KRAS: current perspectives and state-of-art review","volume":"15","author":"Parikh","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2025.07.018_bib73","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1200\/JCO.23.01134","article-title":"ONC201 (dordaviprone) in recurrent H3 K27M-mutant diffuse midline glioma","volume":"42","author":"Arrillaga-Romany","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2025.07.018_bib74","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/2159-8290.CD-17-1119","article-title":"First-in-class ERK1\/2 inhibitor ulixertinib (BVD-523) in patients with MAPK mutant advanced solid tumors: results of a phase I dose-escalation and expansion study","volume":"8","author":"Sullivan","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2025.07.018_bib75","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1080\/15548627.2021.1900498","article-title":"Combination of autophagy and NFE2L2\/NRF2 activation as a treatment approach for neuropathic pain","volume":"17","author":"Li","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2025.07.018_bib76","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1158\/2159-8290.CD-RW2020-019","article-title":"PIK3CA mutations induce neuronal hyperactivity during glioma formation","volume":"10","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2025.07.018_bib77","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41586-023-06835-6","article-title":"Base-editing mutagenesis maps alleles to tune human T cell functions","volume":"625","author":"Schmidt","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.07.018_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2022.08.012","article-title":"Structure of the RAF1\u2013HSP90\u2013CDC37 complex reveals the basis of RAF1 regulation","volume":"82","author":"Garc\u00eda-Alonso","year":"2022","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2025.07.018_bib79","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jhep.2023.08.024","article-title":"Immunosuppressive CD10+ALPL+ neutrophils promote resistance to anti-PD-1 therapy in HCC by mediating irreversible exhaustion of T cells","volume":"79","author":"Meng","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2025.07.018_bib80","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0149-16.2017","article-title":"Activation of Ras-ERK signaling and GSK-3 by amyloid precursor protein and amyloid beta facilitates neurodegeneration in Alzheimer\u2019s disease","volume":"4","author":"Kirouac","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.apsb.2025.07.018_bib81","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aam6790","article-title":"Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's disease","volume":"10","author":"Chen","year":"2017","journal-title":"Sci Signal"},{"key":"10.1016\/j.apsb.2025.07.018_bib82","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/jnr.22039","article-title":"Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene","volume":"87","author":"Wang","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.apsb.2025.07.018_bib83","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1016\/j.febslet.2007.11.053","article-title":"Epac signaling pathway involves STEF, a guanine nucleotide exchange factor for Rac, to regulate APP processing","volume":"581","author":"Zaldua","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.apsb.2025.07.018_bib84","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/15548627.2023.2252300","article-title":"Phosphorylation-state dependent intraneuronal sorting of A\u03b2 differentially impairs autophagy and the endo-lysosomal system","volume":"20","author":"Kapadia","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2025.07.018_bib85","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1093\/brain\/awae092","article-title":"APP antisense oligonucleotides reduce amyloid-\u03b2 aggregation and rescue endolysosomal dysfunction in Alzheimer's disease","volume":"147","author":"Hung","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.apsb.2025.07.018_bib86","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s13238-019-0641-0","article-title":"Inhibition of Rac1-dependent forgetting alleviates memory deficits in animal models of Alzheimer's disease","volume":"10","author":"Wu","year":"2019","journal-title":"Protein Cell"},{"key":"10.1016\/j.apsb.2025.07.018_bib87","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40035-020-00206-1","article-title":"Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease","volume":"9","author":"Shen","year":"2020","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.apsb.2025.07.018_bib88","doi-asserted-by":"crossref","first-page":"8639","DOI":"10.1002\/alz.14308","article-title":"Pathway enrichment in genome-wide analysis of longitudinal Alzheimer's disease biomarker endophenotypes","volume":"20","author":"Rosewood","year":"2024","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.apsb.2025.07.018_bib89","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41398-025-03348-w","article-title":"Identification of genetic architecture shared between schizophrenia and Alzheimer's disease","volume":"15","author":"Liu","year":"2025","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.apsb.2025.07.018_bib90","article-title":"Alzheimer's disease drug development pipeline: 2023","volume":"9","author":"Cummings","year":"2023","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.apsb.2025.07.018_bib91","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/d41573-020-00217-7","article-title":"Failure of first anti-tau antibody in Alzheimer disease highlights risks of history repeating","volume":"20","author":"Mullard","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2025.07.018_bib92","article-title":"Equity, diversity, and inclusion at the global Alliance for genomics and health","volume":"3","author":"Skantharajah","year":"2023","journal-title":"Cell Genom"},{"key":"10.1016\/j.apsb.2025.07.018_bib93","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/brainsci12050552","article-title":"Advances in recapitulating Alzheimer's disease phenotypes using human induced pluripotent stem cell-based in vitro models","volume":"12","author":"Hasan","year":"2022","journal-title":"Brain Sci"},{"key":"10.1016\/j.apsb.2025.07.018_bib94","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/j.apsb.2025.02.035","article-title":"Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged \u03b2-amyloid nanoscavenger for Alzheimer's disease therapy","volume":"15","author":"Xu","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.07.018_bib95","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14924","article-title":"Modulating neuroinflammation and cognitive function in postoperative cognitive dysfunction via CCR5\u2013GPCRs\u2013Ras\u2013MAPK pathway targeting with microglial EVs","volume":"30","author":"Qi","year":"2024","journal-title":"CNS Neurosci Ther"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525004939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525004939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:22:43Z","timestamp":1772774563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525004939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":95,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2211383525004939"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.07.018","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A computational medicine framework integrating multi-omics, systems biology, and artificial neural networks for Alzheimer's disease therapeutic discovery","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}